2020 American Transplant Congress
Incidence, Clinical Correlates and Outcomes of Pulmonary Hypertension after Kidney Transplantation: Analysis of Linked U.S. Registry and Medicare Billing Claims
*Purpose: To describe the incidence and mortality implications of pulmonary hypertension (P-HTN) in a large, national cohort of US kidney transplant (KTx) recipients.*Methods: We examined…2020 American Transplant Congress
Takotsubo Cardiomyopathy Following Liver Transplantation: A Single Center Experience
*Purpose: Takotsubo cardiomyopathy also known as apical ballooning syndrome and stress-induced cardiomyopathy is a syndrome characterized by regional left ventricular systolic dysfunction that resembles myocardial…2020 American Transplant Congress
Bilateral Lung Transplantation Combined with Cardiac Correction in Treatment of Severe Pulmonary Arterial Hypertension Complicated with Eisenmenger Syndrome in Puerpera, a Feasible Strategy for Future?
*Purpose: Though pregnancy is not recommended for patients with pulmonary arterial hypertension (PAH) in current guidelines, some patients do stick to parturition due to varies…2019 American Transplant Congress
Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension
*Purpose: Heart-lung transplants (HLTx) is the only one effective strategy for advanced pulmonary arterial hypertension (PAH) with refractory right heart failure. But limited availability of…2018 American Transplant Congress
The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis
Background: Portopulmonary hypertension(PPH) was once regarded as a contraindicaton in liver transplantation(LT).However,growing evidence indicated that PPH patients underwent LT may show similar outcomes compared to…2017 American Transplant Congress
Preoperative Pulmonary Hypertension Is Not Associated with Adverse Outcomes After Lung Transplantation.
Purpose: The effect of preoperative pulmonary hypertension (PH)[mdash]that is, mean pulmonary artery pressure (mPAP) of 25mmHg or higher[mdash]on lung transplantation (LTx) outcomes is debatable.Methods: We…2017 American Transplant Congress
Retrospective Review of Early versus Late Initiation of Oral Sildenafil for Right Ventricular Dysfunction in Post-Cardiac Transplant Surgery Patients.
University Health Network, Toronto, Canada
Background: Right ventricular (RV) dysfunction is a serious complication that may occur after cardiac transplant and result in graft failure or death. Inotropes (i.e., epinephrine,…2017 American Transplant Congress
WHO Group II Pulmonary Hypertension Is Associated with Decreased Survival in Patients Awaiting Liver Transplantation.
Medicine, Houston Methodist Hospital, Houston, TX
End stage liver disease (ESLD) patients with cirrhotic cardiomyopathy often have WHO Group II pulmonary hypertension (PH), characterized by pulmonary capillary wedge pressure (PCWP) >15…2016 American Transplant Congress
Pulmonary Hypertension in Renal Transplant Candidates: A Systematic Review and Meta-Analysis of the Available Evidence.
Background: Pulmonary hypertension (PHT) is common in patients with end stage renal disease (ESRD). Moderate to severe PHT is a strong independent predictor of mortality…2015 American Transplant Congress
Association of Pulmonary Hypertension at Kidney Transplant Evaluation and Subsequent Outcomes Following Transplantation
Background - Pulmonary hypertension (PH) is common among patients with end stage renal disease (ESRD) who depend on dialysis before transplant, and PH is associated…
American Transplant Congress abstracts